Attached files
| file | filename |
|---|---|
| EX-32.2 - EX-32.2 - T2 Biosystems, Inc. | ttoo-20151231ex32282231f.htm |
| EX-21.1 - EX-21.1 - T2 Biosystems, Inc. | ttoo-20151231ex211f35c14.htm |
| EX-32.1 - EX-32.1 - T2 Biosystems, Inc. | ttoo-20151231ex3217cee00.htm |
| EX-10.6 - EX-10.6 - T2 Biosystems, Inc. | ttoo-20151231ex10618ebeb.htm |
| EX-10.26 - EX-10.26 - T2 Biosystems, Inc. | ttoo-20151231ex10265044c.htm |
| EX-31.1 - EX-31.1 - T2 Biosystems, Inc. | ttoo-20151231ex311cdd34a.htm |
| EX-10.25 - EX-10.25 - T2 Biosystems, Inc. | ttoo-20151231ex10254de6f.htm |
| EX-10.27 - EX-10.27 - T2 Biosystems, Inc. | ttoo-20151231ex10278640a.htm |
| 10-K - 10-K - T2 Biosystems, Inc. | ttoo-20151231x10k.htm |
| EX-31.2 - EX-31.2 - T2 Biosystems, Inc. | ttoo-20151231ex312b286a1.htm |
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the following Registration Statements (Form S-3 No. 333-206707 and Form S-8 Nos. 333-197946) of T2 Biosystems, Inc. and in the related Prospectus of our report dated March 9, 2016, with respect to the consolidated financial statements of T2 Biosystems, Inc. included in this Annual Report (Form 10-K) for the year ended December 31, 2015.
|
|
/s/ Ernst & Young LLP |
Boston, Massachusetts
March 9, 2016